RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

JCR Pharmaceuticals Co P/E 2024

JCR Pharmaceuticals Co P/E

9.83

JCR Pharmaceuticals Co Dividend yield

3.13 %

Ticker

4552.T

ISIN

JP3701000006

WKN

889627

As of May 15, 2024, JCR Pharmaceuticals Co's P/E ratio was 9.83, a -78.43% change from the 45.57 P/E ratio recorded in the previous year.

The JCR Pharmaceuticals Co P/E history

JCR Pharmaceuticals Co Aktienanalyse

What does JCR Pharmaceuticals Co do?

JCR Pharmaceuticals Co. Ltd is a Japanese company founded in 1975. It is a global provider of biopharmaceutical products and services and is based in Ashiya, Japan. The company specializes in researching and developing therapies for rare genetic diseases, including the production of recombinant proteins and antibodies. It has three main business areas: biopharmaceuticals, diagnostics, and research services. JCR Pharmaceuticals works closely with universities, research institutions, and other companies to advance biotechnology research. It follows an ethical business model focused on integrity, transparency, openness, and fairness. The company has expanded into Europe and invested in a new research and development facility to enhance its presence and improve access to novel therapies for patients. Overall, JCR Pharmaceuticals has a strong position in the biotechnology and rare diseases field and has the potential to positively impact the lives of millions of people worldwide. JCR Pharmaceuticals Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering JCR Pharmaceuticals Co's P/E Ratio

The Price to Earnings (P/E) Ratio of JCR Pharmaceuticals Co is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing JCR Pharmaceuticals Co's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of JCR Pharmaceuticals Co is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in JCR Pharmaceuticals Co’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about JCR Pharmaceuticals Co Stock

What is the price-to-earnings ratio of JCR Pharmaceuticals Co?

The price-earnings ratio of JCR Pharmaceuticals Co is currently 9.83.

How has the price-earnings ratio of JCR Pharmaceuticals Co changed compared to last year?

The price-to-earnings ratio of JCR Pharmaceuticals Co has increased by -78.43% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of JCR Pharmaceuticals Co high compared to other companies?

Yes, the price-to-earnings ratio of JCR Pharmaceuticals Co is high compared to other companies.

How does an increase in the price-earnings ratio of JCR Pharmaceuticals Co affect the company?

An increase in the price-earnings ratio of JCR Pharmaceuticals Co would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of JCR Pharmaceuticals Co affect the company?

A decrease in the price-earnings ratio of JCR Pharmaceuticals Co would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of JCR Pharmaceuticals Co?

Some factors that influence the price-earnings ratio of JCR Pharmaceuticals Co are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does JCR Pharmaceuticals Co pay?

Over the past 12 months, JCR Pharmaceuticals Co paid a dividend of 20 JPY . This corresponds to a dividend yield of about 3.13 %. For the coming 12 months, JCR Pharmaceuticals Co is expected to pay a dividend of 24.33 JPY.

What is the dividend yield of JCR Pharmaceuticals Co?

The current dividend yield of JCR Pharmaceuticals Co is 3.13 %.

When does JCR Pharmaceuticals Co pay dividends?

JCR Pharmaceuticals Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of JCR Pharmaceuticals Co?

JCR Pharmaceuticals Co paid dividends every year for the past 24 years.

What is the dividend of JCR Pharmaceuticals Co?

For the upcoming 12 months, dividends amounting to 24.33 JPY are expected. This corresponds to a dividend yield of 3.8 %.

In which sector is JCR Pharmaceuticals Co located?

JCR Pharmaceuticals Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von JCR Pharmaceuticals Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of JCR Pharmaceuticals Co from 6/1/2024 amounting to 10 JPY, you needed to have the stock in your portfolio before the ex-date on 3/28/2024.

When did JCR Pharmaceuticals Co pay the last dividend?

The last dividend was paid out on 6/1/2024.

What was the dividend of JCR Pharmaceuticals Co in the year 2023?

In the year 2023, JCR Pharmaceuticals Co distributed 20 JPY as dividends.

In which currency does JCR Pharmaceuticals Co pay out the dividend?

The dividends of JCR Pharmaceuticals Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von JCR Pharmaceuticals Co

Our stock analysis for JCR Pharmaceuticals Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of JCR Pharmaceuticals Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.